Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q2 2020 Earnings

7MayConfirmed

Q3 2019

Q4 2019

Q1 2020

Q2 2020

-0.57

-0.48

-0.38

-0.29

Details

Expected EPS

-0.49

Actual EPS

-0.57

Surprise EPS

-0.08

Surprise Percent

+16.33%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.57 per share for Q2 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.